16 October, 2011
A federal judge presiding over Avandia litigation denied drug maker GlaxoSmithKline’s motion to dismiss 60 Avandia lawsuits on statute of limitations grounds. GSK attempted to convince the judge that the claims were filed too late. Continue reading Avandia statute of limitations ruling allows new lawsuits to proceed
Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements | Avandia Side Effects